Who are the top serial entrepreneurs in biotech? What kind of person does it take to enter a company at the beginning, or at a nascent stage of high ambiguity, and find a way to create value? Hear more about what makes these people tick, and what they do that has worked time and again.
Moderator: Luke Timmerman – Timmerman Report
- Tilman Gerngross – Adimab
- Michael Gilman – Formerly Padlock Therapeutics; Atlas Venture
- Troy Wilson – Kura Oncology